Shao-Xiu Ji

Active ingredients and molecular targets of Taraxacum mongolicum against hepatocellular carcinoma: network pharmacology, molecular docking, and molecular dynamics simulation analysis

Xia Li, Yan Zheng, Quansheng Feng, 2022, PeerJ.

Epidemiological investigation and proteomic profiling of typical TCM syndrome in HIV/AIDS immunological nonresponders

Xia Li, Xin Chen, Yan Zheng, 2022, Anatomical record.

Sorafenib Attenuates Fibrotic Hepatic Injury Through Mediating Lysine Crotonylation

Shao-Xiu Ji, Xiao-feng Chen, 2022, Drug design, development and therapy.

Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis

Chao Liu, Quansheng Feng, Yumei Wang, 2022, Frontiers in Pharmacology.

DDDT_A_368306 2133..2144

Shao-Xiu Ji, Xiao-feng Chen, 2022 .

Persistent Lipid Accumulation Leads to Persistent Exacerbation of Endoplasmic Reticulum Stress and Inflammation in Progressive NASH via the IRE1α/TRAF2 Complex

Quansheng Feng, Jibin Liu, L. Zeng, 2023, Molecules.

TMT-based proteomics analysis identifies the interventional mechanisms of Qijia Rougan decoction in improving hepatic fibrosis.

Han Yu, Pei-Gen Wu, Shao-Xiu Ji, 2023, Journal of ethnopharmacology.

Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1/STAT6-microRNA-23a feedback loop in macrophage M2 polarization.

Yan Zheng, Shao-Xiu Ji, Xia Li, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.